Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients.

[1]  E. Bonora,et al.  Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. , 2015, Metabolism: clinical and experimental.

[2]  G. Sesti,et al.  Association between Noninvasive Fibrosis Markers and Cardio-Vascular Organ Damage among Adults with Hepatic Steatosis , 2014, PloS one.

[3]  E. Brunt,et al.  Role of liver biopsy in nonalcoholic fatty liver disease. , 2014, World journal of gastroenterology.

[4]  Hong Liu,et al.  Nonalcoholic fatty liver disease and cardiovascular disease. , 2014, World journal of gastroenterology.

[5]  S. Park,et al.  Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. , 2014, The Journal of clinical endocrinology and metabolism.

[6]  C. Mantzoros,et al.  Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. , 2014, Metabolism: clinical and experimental.

[7]  E. Bjornsson,et al.  Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. , 2013, Gastroenterology.

[8]  Y. Chawla,et al.  Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease. , 2013, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[9]  G. Lupattelli,et al.  Insulin resistance and not BMI is the major determinant of early vascular impairment in patients with morbid obesity. , 2013, Journal of atherosclerosis and thrombosis.

[10]  Z. Younossi,et al.  In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. , 2013, Metabolism: clinical and experimental.

[11]  Sombat Treeprasertsuk,et al.  NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. , 2013, World journal of gastroenterology.

[12]  Y. Yılmaz,et al.  Assessment of endothelial function in patients with nonalcoholic fatty liver disease , 2013, Endocrine.

[13]  J. Lekakis,et al.  Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[14]  Enzo Bonora,et al.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[15]  H. Yki-Järvinen.  Liver Fat in the Pathogenesis of Insulin Resistance and Type 2 Diabetes , 2010, Digestive Diseases.

[16]  D. Kim,et al.  Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. , 2009, Atherosclerosis.

[17]  Chunhong Bai,et al.  Long-term follow-up of patients with nonalcoholic fatty liver. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  Norbert Stefan,et al.  Causes and metabolic consequences of Fatty liver. , 2008, Endocrine reviews.

[19]  L. N. Valenti,et al.  Carotid artery intima-media thickness in nonalcoholic fatty liver disease. , 2008, The American journal of medicine.

[20]  Manisha Talim,et al.  Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients , 2007, Diabetes Care.

[21]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[22]  J. Takeda,et al.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. , 2007, World journal of gastroenterology.

[23]  G. Zoppini,et al.  Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled Type 2 diabetic patients , 2006, Journal of endocrinological investigation.

[24]  H. Lo,et al.  Sonographic fatty liver, overweight and ischemic heart disease. , 2005, World journal of gastroenterology.

[25]  B. Matsuura,et al.  A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. , 2005, Internal medicine.

[26]  G. Marchesini,et al.  Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease , 2005, Hepatology.

[27]  Emilio Ros,et al.  Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Z. Goodman,et al.  Predictors of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Morbidly Obese Patients , 2005, Obesity surgery.

[29]  P. Angulo,et al.  Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.

[30]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[31]  D. Kotler,et al.  Liver Pathology in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass Surgery , 2002, Obesity surgery.

[32]  J. Werba,et al.  Common Carotid Intima‐Media Thickness Measurement: A Method to Improve Accuracy and Precision , 1994, Stroke.